Paper20879880
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Baker DL and 15 others. N Engl J Med, 2010. Cited by 228 papers, by iCite.
Cite this record
ConductScience Library. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. Papers, record 20879880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20879880
- Disease
- neuroblastoma173 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Phase III, Journal Article, Research Support, N.I.H., Extramural
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Neuroblastoma | Major topic |
| Carboplatin | |
| Child | |
| Child, Preschool | |
| Cyclophosphamide | |
| Doxorubicin | |
| Etoposide | |
| Humans | |
| Infant | |
| Intention to Treat Analysis | |
| Neoplasm Staging | |
| Prospective Studies | |
| Survival Analysis | |
| Treatment Outcome |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UI0-CA29139 | NCI NIH HHS | United States | U10CA029139 | PubMed and NIH | NIH RePORTER |
| U10 CA098413 | NCI NIH HHS | United States | U10CA098413 | PubMed and NIH | NIH RePORTER |
| UI0-CA98413 | NCI NIH HHS | United States | U10CA098413 | PubMed and NIH | NIH RePORTER |
| UI0-CA98543 | NCI NIH HHS | United States | U10CA098543 | PubMed and NIH | NIH RePORTER |
| U10 CA029139 | NCI NIH HHS | United States | U10CA029139 | PubMed and NIH | NIH RePORTER |
| U10 CA098543 | NCI NIH HHS | United States | U10CA098543 | PubMed and NIH | NIH RePORTER |
| U10 CA017829 | NCI NIH HHS | United States | U10CA017829 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00003093 | Combination Chemotherapy in Treating Children With Neuroblastoma | Results | Yes |
Source ClinicalTrials.gov
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1323992 | Cisplatin therapy in infants: short and long-term morbidity. | Br J Cancer Suppl | 1992 | https://conductscience.org/library/papers/1323992 | PubMed |
| 2 | 7620924 | Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma. | J Pediatr Hematol Oncol | 1995 | https://conductscience.org/library/papers/7620924 | PubMed |
| 3 | 6738617 | Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6738617 | PubMed |
| 4 | 18349403 | Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18349403 | PubMed |
| 5 | 1579408 | Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. | Pediatrics | 1992 | https://conductscience.org/library/papers/1579408 | PubMed |
| 6 | 9060959 | Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study. | J Natl Cancer Inst | 1997 | https://conductscience.org/library/papers/9060959 | PubMed |
| 7 | 17035650 | Chronic health conditions in adult survivors of childhood cancer. | N Engl J Med | 2006 | https://conductscience.org/library/papers/17035650 | PubMed |
| 8 | 9516866 | Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group. | Eur J Cancer | 1997 | https://conductscience.org/library/papers/9516866 | PubMed |
| 9 | 2045858 | Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study. | J Clin Oncol | 1991 | https://conductscience.org/library/papers/2045858 | PubMed |
| 10 | 2066755 | Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. | J Clin Oncol | 1991 | https://conductscience.org/library/papers/2066755 | PubMed |
| 11 | 7553646 | Significance of chromosome 1p loss of heterozygosity in neuroblastoma. | Cancer Res | 1995 | https://conductscience.org/library/papers/7553646 | PubMed |
| 12 | 10490829 | Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. | Oncogene | 1999 | https://conductscience.org/library/papers/10490829 | PubMed |
| 13 | 17586306 | Neuroblastoma. | Lancet | 2007 | https://conductscience.org/library/papers/17586306 | PubMed |
| 14 | 9626197 | Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. | J Clin Oncol | 1998 | https://conductscience.org/library/papers/9626197 | PubMed |
| 15 | 9552023 | Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. | J Clin Oncol | 1998 | https://conductscience.org/library/papers/9552023 | PubMed |
| 16 | 17974716 | Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group. | Pediatrics | 2007 | https://conductscience.org/library/papers/17974716 | PubMed |
| 17 | 16314642 | Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/16314642 | PubMed |
| 18 | 19047290 | The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19047290 | PubMed |
| 19 | 19047291 | The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19047291 | PubMed |
| 20 | 8176583 | The surgical challenge of neuroblastoma. | J Pediatr Surg | 1994 | https://conductscience.org/library/papers/8176583 | PubMed |
Cited by133
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42591963 | Vasoactive Intestinal Peptide (VIP)-Secreting Neuroblastic Tumors in Children Presenting With Chronic Secretory Diarrhea: A Report of Two Cases. | Cureus | 2026 | https://conductscience.org/library/papers/42591963 | PubMed |
| 42449647 | Strategies to Improve Sensitivity to Radiotherapy in Pediatric Solid Tumors. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449647 | PubMed |
| 42385103 | Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/42385103 | PubMed |
| 42277674 | Clinical analysis and prognostic factors in children with neuroblastoma-associated opsoclonus-myoclonus syndrome: a multicenter retrospective study. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42277674 | PubMed |
| 41958679 | Mechanism by which SAHA regulates HLA-E expression via the endoplasmic reticulum stress-related PERK/ATF4/CHOP pathway in neuroblastoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/41958679 | PubMed |
| 41682783 | Neuroblastoma in Childhood: Biological Insights, Risk Stratification, and Advances in Multimodal Therapy. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682783 | PubMed |
| 41545871 | Activation of the pituitary adenylate cyclase-activating polypeptide type I receptor promotes neuroblastoma proliferation and migration through distinct G protein pathways. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41545871 | PubMed |
| 41530803 | The safety and efficacy of GD2-targeted CAR-T cells in patients with neuroblastoma: a systematic review and meta-analysis. | Eur J Med Res | 2026 | https://conductscience.org/library/papers/41530803 | PubMed |
| 41392230 | Lessons learned from different prognostic factors analysis in intermediate-risk neuroblastoma: ten years' experience at a tertiary center. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/41392230 | PubMed |
| 41231348 | Busulfan and melphalan (Bu-Mel) versus carboplatin, etoposide, and melphalan (CEM) conditioning regimens for autologous haematopoietic stem cell transplant in children and young adults with high-risk neuroblastoma. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/41231348 | PubMed |
| 40787276 | Therapeutic Innovation in Pediatric Neuroblastoma: Age and Stage-Specific Strategies from Prenatal to Early Childhood-A Review Article. | Iran J Child Neurol | 2025 | https://conductscience.org/library/papers/40787276 | PubMed |
| 40539008 | Horner syndrome in a pediatric patient. | Pediatr Investig | 2025 | https://conductscience.org/library/papers/40539008 | PubMed |
| 40351327 | Characteristics, treatments, and outcomes of adolescents and adults with neuroblastoma: a retrospective study in China. | Ther Adv Med Oncol | 2025 | https://conductscience.org/library/papers/40351327 | PubMed |
| 40163752 | Associations between Tumor Ploidy and Overall Survival in Pediatric Neuroblastoma. | P R Health Sci J | 2025 | https://conductscience.org/library/papers/40163752 | PubMed |
| 39981455 | Development of Neuroblastoma During Growth Hormone Therapy for Short Stature in a Girl With Mosaic Turner Syndrome. | Cureus | 2025 | https://conductscience.org/library/papers/39981455 | PubMed |
| 39796644 | Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39796644 | PubMed |
| 39725722 | Impact of the relationship between renal pedicles and tumors on surgical outcomes for non-high-risk abdominal neuroblastoma. | Pediatr Surg Int | 2024 | https://conductscience.org/library/papers/39725722 | PubMed |
| 39594898 | Unveiling Tumorigenesis Mechanisms and Drug Therapy in Neuroblastoma by Mass Spectrometry Based Proteomics. | Children (Basel) | 2024 | https://conductscience.org/library/papers/39594898 | PubMed |
| 39317567 | Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. | J Pediatr Surg | 2025 | https://conductscience.org/library/papers/39317567 | PubMed |
| 39199637 | Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199637 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CSF3 | 1440 | PubTator's text mining | https://conductscience.org/library/genes/1440 | NCBI Gene |
| FANCL | 55120 | PubTator's text mining | https://conductscience.org/library/genes/55120 | NCBI Gene |
| MYCN | 4613 | PubTator's text mining | https://conductscience.org/library/genes/4613 | NCBI Gene |
Drugs6
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| CYCLOPHOSPHAMIDE | CHEMBL1200796 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1200796 | ChEMBL |
| FILGRASTIM | CHEMBL1201567 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201567 | ChEMBL |
| SARGRAMOSTIM | CHEMBL1201670 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201670 | ChEMBL |
| CARBOPLATIN | CHEMBL1351 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1351 | ChEMBL |
| DOXORUBICIN HYDROCHLORIDE | CHEMBL359744 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL359744 | ChEMBL |
| ETOPOSIDE | CHEMBL44657 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL44657 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20879880
GET https://conductscience.org/api/papers/v1/20879880/references?page=2